Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 0115-1436

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0115-1436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cyclobenzaprine Hydrochloride Extended Release Cap 1)

Chemical structure of Cyclobenzaprine Hydrochloride, showing the bicyclic ring system attached to a side chain with nitrogen and methyl groups, including the hydrochloride salt component.*

FDA Label Image

Ndc 0115-1436-13 (Cyclobenzaprine Hydrochloride Extended Release Cap 2)

An illustration showing a spoon holding a small amount of granular or powdered substance. The image depicts a close-up, simple black and white line drawing of the spoon with the substance.*

FDA Label Image

Ndc 0115-1437-13 (Cyclobenzaprine Hydrochloride Extended Release Cap 3)

An instructional illustration showing a hand holding and opening a capsule labeled 'TOP' by separating its two halves, indicating how to open a Cyclobenzaprine Hydrochloride extended-release oral capsule.*

FDA Label Image

Cyclobenzaprine Hydrochloride Extended Release Cap 4

An instructional illustration showing a person using their hands to twist and open a capsule labeled with 'TCI'. The image demonstrates the method of breaking the capsule apart by twisting it between the fingers.*

FDA Label Image

Cyclobenzaprine Hydrochloride Extended Release Cap 5

An instructional illustration showing a hand sprinkling capsule contents onto a spoon. The image is likely demonstrating how to open the capsule and use its contents, relevant to Cyclobenzaprine Hydrochloride extended-release capsules.*

FDA Label Image

Cyclobenzaprine Hydrochloride Extended Release Cap 6

Illustration of a person holding a capsule or pill near their mouth, demonstrating the act of taking an oral medication dose.*

FDA Label Image

Cyclobenzaprine Hydrochloride Extended Release Cap 7

An illustration showing a person drinking a glass of liquid, likely demonstrating how to take an oral medication.*

FDA Label Image

Cyclobenzaprine Hydrochloride Extended Release Cap 8

Label for Cyclobenzaprine Hydrochloride Extended-Release Capsules, 15 mg strength. The label includes dosage form as capsules, an orange box highlighting the 15 mg strength, and states a quantity of 60 capsules. It is manufactured and distributed by Amneal Pharmaceuticals of New York LLC. The label includes an NDC number 0115-1436-13 and storage instructions.*

FDA Label Image

Cyclobenzaprine Hydrochloride Extended Release Cap 9

Label for Cyclobenzaprine Hydrochloride Extended-Release Capsules, 30 mg, oral dosage form. The label indicates the product is prescription only with a count of 60 capsules. It is manufactured by Amneal Pharmaceuticals of New York LLC. The label includes dosage instructions and storage conditions, along with a barcode and NDC number 0115-1437.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.